Predicted mean age at Tanner stage transitions by inhibitor status for HIV− adolescents
| Tanner stage . | Age without inhibitor, y . | Age with inhibitor, y . | Difference, mo . | 95% CI, mo . | P . |
|---|---|---|---|---|---|
| 1-2 | 12.5 | 13.2 | 9.2 | 3.1, 15.2 | .003 |
| 2-3 | 13.4 | 14.1 | 8.0 | 1.1, 14.9 | .02 |
| 3-4 | 14.6 | 15.2 | 7.5 | 0.6, 14.3 | .03 |
| 4-5 | 16.0 | 16.3 | 3.7 | −2.8, 10.2 | .27 |
| Tanner stage . | Age without inhibitor, y . | Age with inhibitor, y . | Difference, mo . | 95% CI, mo . | P . |
|---|---|---|---|---|---|
| 1-2 | 12.5 | 13.2 | 9.2 | 3.1, 15.2 | .003 |
| 2-3 | 13.4 | 14.1 | 8.0 | 1.1, 14.9 | .02 |
| 3-4 | 14.6 | 15.2 | 7.5 | 0.6, 14.3 | .03 |
| 4-5 | 16.0 | 16.3 | 3.7 | −2.8, 10.2 | .27 |
A total of 1051 evaluations from 114 HIV− participants were used in the analysis; 89 evaluations from 12 participants were excluded from the analysis because they were already Tanner stage 5 at baseline.